Neuss, 41460, Germany
NCT Number: NCT00772356
A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes
This crossover, glucose-clamp study will investigate the impact of different basal insulin infusion rates on glucose control employing insulin pumps with different insulin delivery regimen. Patients will be randomized in one of 2 groups, to receive on the first study day insulin via pumps with pulsatile or quasi-continuous delivery modes. On the second study day they will be switched to treatment with the alternative delivery regimen. The anticipated duration of the trial is 2 study days and the target sample size is 14 individuals.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male patients 18-65 years of age
- Type I diabetes mellitus
- Currently on continuous subcutaneous insulin infusion therapy
Exclusion criteria
- Proliferative retinopathy or maculopathy requiring actue treatment within last 6 months
- Use of systemic corticoids in last 3 months
- Treatment with medication known to interfere with glucose metabolism
Treatment and study plan
Accu-Chek Spirit Insulin Pump
DeviceComparator insulin pump
DevicePrimary outcomes
-
Comparison of glucose infusion rate necessary to keep blood glucose constant
Time frame: Throughout study
Secondary outcomes
-
Serum insulin and free fatty acid levels
Time frame: Throughout study
Sponsors and collaborators
Lead sponsor
Hoffmann-La Roche
Industry
Registry information
Important dates
- Study start
- 2008
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Oct 15, 2008
- Registry last updated
- Mar 3, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
NCT02624804
Autoimmune Diseases, Diabetes Mellitus
Hackensack, New Jersey, United States
View Trial DetailsReal-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop
NCT07015970
Autoimmune Diseases, Diabetes Mellitus
Caen, France
View Trial DetailsFeasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry
NCT06088615
Autoimmune Diseases, Diabetes Mellitus
Ulm, Baden-Wurttemberg, Germany
View Trial DetailsSolitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
NCT00006505
Autoimmune Diseases, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial Details